Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
ProQR Therapeutics
Biotech
Lilly doubles down on ProQR's RNA tech in $75M deal expansion
RNA expert ProQR is ending a tough year on a high note thanks to a $75 million expansion of a genetic medicines partnership with Eli Lilly.
Annalee Armstrong
Dec 22, 2022 10:38am
After a year of 'right sizing,' will biotech rebloom in 2023?
Dec 22, 2022 5:00am
Biotechs cut pipeline prospects to focus on priority programs
Aug 11, 2022 9:43am
Former AbbVie R&D chief tapped to run Tessera—Chutes & Ladders
Jun 3, 2022 9:30am
ProQR slashes 30% of workforce following phase 2/3 blunder
Apr 13, 2022 11:47am
ProQR treatment for congenital eye disease flops in trials
Feb 11, 2022 11:30am
